Related Experiment Videos
Changes in rat liver nuclear protein metabolism following a single carcinogenic dose of diethylnitrosamine
Experimentelle Pathologie
|January 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER.
ESMO gastrointestinal oncology·2026
The impact of COVID-19 on surgical training: a systematic review.
Techniques in coloproctology·2021
Effect of publishing surgeon-specific outcomes on surgical training.
The British journal of surgery·2019
The effects of human factor related issues on assessors during the recruitment process for general and vascular surgery in the UK.
Annals of the Royal College of Surgeons of England·2019
Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Stimulatory effect of platelet homogenate on collagen biosynthesis in L-929 cells.
Experimentelle Pathologie·1980
The effect of methylnitrosourea intoxication on the fatty acid pattern of myelin lipids.
Experimentelle Pathologie·1980
Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs.
Experimentelle Pathologie·1980
Long-term tissue culture of human pheochromocytomas.
Experimentelle Pathologie·1980
Senomorphic miR-3155b suppresses the senescence-associated secretory phenotype in therapy-induced senescence.
Frontiers in cell and developmental biology·2026
Predictive biomarkers for precision treatment in rheumatoid arthritis: are we there yet?
Frontiers in pharmacology·2026
Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies.
Frontiers in immunology·2026
Profiling crystal engineered ligands for targeting treatment resistant androgen receptors.
Frontiers in pharmacology·2026